Endo Pharmaceuticals Contributes More Than 200,000 Synera(R) Patches to AmeriCares

CHADDS FORD, Pa., June 13 /PRNewswire-USNewswire/ -- Endo Pharmaceuticals Inc. today announced the donation of more than 200,000 Synera(R) (lidocaine 70 mg / tetracaine 70 mg) topical patches to the humanitarian organization AmeriCares, a non-profit international relief organization that delivers medicines and medical supplies to people in need around the globe. AmeriCares partners with local health care providers in more than 30 countries and plans to distribute the topical anesthetic patches to those who have requested the product in order to limit the pain children experience during superficial venous access procedures.

“One of the most difficult health issues in developing countries is that many people lack access to medicine,” said Curt Welling, President and Chief Executive Officer of AmeriCares. “AmeriCares is grateful to Endo for giving us the ability to provide a much needed product to thousands of children around the world who are unable to get the care they desperately need.”

“We feel extraordinarily privileged to partner with an organization that has helped so many when help was needed most,” said Peter A. Lankau, President and Chief Executive Officer of Endo Pharmaceuticals Inc. “We hope this charitable donation will help provide relief to those who need it around the world and we are proud to support AmeriCares’ mission.”

Important Information about SYNERA

SYNERA is a topical anesthetic approved in the United States for use on intact skin to provide local dermal analgesia for superficial venous access and superficial dermatological procedures in both children 3 years and older and adults.

SYNERA is contraindicated in patients with a known history of sensitivity to lidocaine, tetracaine, or any other component of the product, and in those patients with para-aminobenzoic acid (PABA) sensitivity. Keeping a patch on longer than recommended or applying multiple patches simultaneously or sequentially could result in systemic absorption sufficient to result in serious adverse events that are typical of drugs in this class.

For Safety Information and/or to learn more about the SYNERA patch, please visit http://www.synera.com.

About Endo

A wholly owned subsidiary of Endo Pharmaceuticals Holdings Inc., Endo Pharmaceuticals Inc. is a fully integrated specialty pharmaceutical company with market leadership in pain management products. The company researches, develops, produces and markets a broad product offering of branded and generic pharmaceuticals, meeting the needs of healthcare professionals and consumers alike. More information, including this and past press releases of Endo Pharmaceuticals Holdings Inc. is available online at www.endo.com.

About AmeriCares

AmeriCares is a nonprofit international relief organization that delivers medicines, medical supplies and aid to people in crisis around the world. Since it was established in 1982, AmeriCares has distributed more than $6.5 billion in humanitarian aid to 137 countries. For six years in a row, AmeriCares has been given a four-star rating from Charity Navigator, the highest possible rating, indicating effective management practices. For more information, log onto www.americares.org.

Endo Pharmaceuticals Inc.

CONTACT: Katie Meginniss of Endo Pharmaceuticals Inc., +1-610-558-9800; orMarissa Magnetti of GCI Group, +1-212-537-8008 for Endo PharmaceuticalsInc.; or Lisa Slow of AmeriCares, +1-203-658-9557

MORE ON THIS TOPIC